Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare
Castle Biosciences, Inc. Operating Income 2018–2025
Castle Biosciences, Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Castle Biosciences, Inc. operating income for the quarter ending March 31, 2026 was -18.4 M, a 34.09% decrease year-over-year.
- Castle Biosciences, Inc. operating income for the twelve months ending March 31, 2026 was -57.4 M, a 1043.23% increase year-over-year.
- Castle Biosciences, Inc. annual operating income for 2025 was -42.8 M, a 593.77% decrease from 2024.
- Castle Biosciences, Inc. annual operating income for 2024 was 8.7 M, a 112.75% decrease from 2023.
- Castle Biosciences, Inc. annual operating income for 2023 was -68.0 M, a 6.70% decrease from 2022.
- Castle Biosciences, Inc. annual operating income for 2022 was -72.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Castle Biosciences, Inc. Operating Income — FAQ
Castle Biosciences, Inc. (CSTL) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Castle Biosciences, Inc.'s operating income?
Castle Biosciences, Inc. (CSTL) reported operating income of -$43M for fiscal 2025.
Where can I see CSTL's operating income history?
The chart and table above show Castle Biosciences, Inc.'s operating income by year and by quarter, including the growth rate.